bioRxiv preprint doi: https://doi.org/10.1101/2020.08.10.244822; this version posted August 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Wiriyasermkul, et al. 1 D-Serine, an emerging biomarker of kidney diseases, is a hidden substrate of 2 sodium-coupled monocarboxylate transporters 3 4 Pattama Wiriyasermkul1, Satomi Moriyama1, Yoko Tanaka1, Pornparn Kongpracha1, Nodoka 5 Nakamae1, Masataka Suzuki2, Tomonori Kimura3,4, Masashi Mita5, Jumpei Sasabe2, Shushi 6 Nagamori1,# 7 8 1Department of Collaborative Research for Biomolecular Dynamics, Nara Medical 9 University, Nara, Japan 10 2Department of Pharmacology, Keio University School of Medicine, Tokyo, Japan 11 3KAGAMI Project, 4Reverse Translational Research Project, Center for Rare Disease 12 Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN). 13 Osaka, Japan 14 5KAGAMI Inc., Osaka, Japan 15 16 # Corresponding contact information:
[email protected] 17 18 19 20 21 Keywords: transporter, proteome, ischemia-reperfusion injury (IRI), acute kidney injury 22 (AKI), chronic kidney diseases (CKD), membrane 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.10.244822; this version posted August 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Wiriyasermkul, et al. 23 Abstract 24 Delay in diagnosis of renal injury has profound impacts on morbidity and mortality.